Thomas Fuller | Lightrocket | Getty ImagesReplimune plans to resubmit its melanoma drug to the Food and Drug Administration for review after a leadership exodus at…
Thomas Fuller | Lightrocket | Getty ImagesReplimune plans to resubmit its melanoma drug to the Food and Drug Administration for review after a leadership exodus at…
Rafael Henrique | Lightrocket | Getty ImagesShares of major vaccine makers dropped on Monday after a key U.S. health official resigned in protest of Health and…